Contribution: Industrial Research Assistance Program – Contributions to Firms
Cytophage Technologies Inc.
$0.00
Addressing Production and Quality Challenges in Commercializing Phage Biologics for Animal Health
FY 2025-26 · 2025-08-01
Summary
This project will advance Cytophage’s Quality Assurance and Quality Control (QA/QC) systems and optimize manufacturing processes for its first bacteriophage-based animal health product. By addressing the unique production challenges of phage biologics, the project will enable GMP-certified manufacturing and support regulatory approval and commercialization of this innovative alternative to antibiotics in animal agriculture.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Oak Bluff|Oak Bluff, Manitoba, Canada
Recipient Type
For-profit organization
Business Number
838709038
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 1 | 2025-08-01 | 2025-26 | $90,000.00 |
| 2 | 2025-08-01 | 2025-26 | $0.00 |
As published
Agreement End Date
2026-12-31
Agreement Number
1032885
Agreement Start Date
2025-08-01
Agreement Title
Addressing Production and Quality Challenges in Commercializing Phage Biologics for Animal Health
Agreement Title (French)
Relever les défis liés à la production et à la qualité dans la commercialisation de produits biologiques à base de phages pour la santé animale
Agreement Type
Contribution
Agreement Value
$0.00
Amendment Date
2026-07-01
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will advance Cytophage’s Quality Assurance and Quality Control (QA/QC) systems and optimize manufacturing processes for its first bacteriophage-based animal health product. By addressing the unique production challenges of phage biologics, the project will enable GMP-certified manufacturing and support regulatory approval and commercialization of this innovative alternative to antibiotics in animal agriculture.
Description (French)
Ce projet permettra d’améliorer les systèmes d’assurance de la qualité et de contrôle de la qualité (AQ/CQ) de Cytophage et d’optimiser les processus de fabrication de son premier produit de santé animale à base de bactériophages. En relevant les défis de production uniques des produits biologiques à base de phages, le projet permettra une fabrication certifiée BPF et soutiendra l’approbation réglementaire et la commercialisation de cette alternative innovante aux antibiotiques dans l’élevage.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Portage--Lisgar
Federal Riding (French)
Portage--Lisgar
Federal Riding Number
46007
NAICS Code
32541
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
838709038
Recipient City
Oak Bluff|Oak Bluff
Recipient Country
CA
Recipient Legal Name
Cytophage Technologies Inc.
Recipient Postal Code
R4G 0B1
Recipient Province or Territory
MB
Recipient Type
F
Reference Number
172-2025-2026-Q2-1032885
